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Abstract 
The field of DNA intelligence focuses on retrieving information from DNA evidence that can help narrow 
down large groups of suspects or define target groups of interest. With recent breakthroughs on the estimation 
of geographical ancestry and physical appearance, the estimation of chronological age comes to complete this 
circle of information. Recent studies have identified methylation sites in the human genome that correlate 
strongly with age and can be used for the development of age-estimation algorithms. In this study, 110 whole 
blood samples from individuals aged 11-93 years were analysed using a DNA methylation quantification assay 
based on bisulphite conversion and massively parallel sequencing (Illumina MiSeq) of 12 CpG sites. Using 
this data, 17 different statistical modelling approaches were compared based on root mean square error 
(RMSE) and a Support Vector Machine with polynomial function (SVMp) model was selected for further 
testing. For the selected model (RMSE= 4.9 years) the mean average error (MAE) of the blind test (n=33) was 
calculated at 4.1 years, with 52% of the samples predicting with less than 4 years of error and 86% with less 
than 7 years. Furthermore, the sensitivity of the method was assessed both in terms of methylation 
quantification accuracy and prediction accuracy in the first validation of this kind. The described method 
retained its accuracy down to 10 ng of initial DNA input or ~2ng bisulphite PCR input. Finally, 34 saliva 
samples were analysed and following basic normalisation, the chronological age of the donors was predicted 
with less than 4 years of error for 50% of the samples and with less than 7 years of error for 70%.  
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1. Introduction 
In a forensic era where intelligence information regarding an individual’s physical appearance can be 
retrieved from DNA material [1-3], the accurate determination of chronological age from crime scene 
samples has the potential to significantly aid forensic investigations towards identifying and finding 
unknown individuals. In the majority of the forensic cases where intact skeletal remains are available, 
age determination can be conducted successfully by anthropological measurements and calculations 
as well as cross-referencing with medical records. In the quest of identifying the perpetrator of a 
crime, however, it is highly unlikely for the biological evidence to consist of something other than 
body fluids, shed hairs and/or fingerprints. In those scenarios, especially when any direct comparisons 
with DNA and/or fingerprint databases are unable to provide a definitive match, the need for an age 
prediction method based on biological material emerges. 
Over recent years, several approaches employing biomarkers for age prediction have been 
investigated. Extensive research has focused on the correlation of age and telomere length [3-9], while 
biomarkers including the quantification of a 4977bp deletion in the mitochondrial genome [10-12], 
measurement of aspartic acid racemisation [13-15], detection of somatic gene rearrangement in T-
cells via its products (sjTRECs) [16], measurement of advanced glycation end product accumulation 
(AGEs) [17] and, finally, analysis of mRNA profiles [18] have also been investigated over the years. 
However, several restrictions including significant effects of variables other than age [9, 19-25], lack 
of precision and reproducibility [26, 27], as well as restrictions in age range [18, 25, 28] and tissue 
applicability [27, 29] are overshadowing the proposed age prediction methods. 
Differentiation in gene expression governs to a significant extent most physiological processes, 
including ageing. As epigenetic factors are known for their key role in modulating gene expression, 
it comes as no surprise that current research on age estimation has navigated heavily towards this area 
[30-32]. Epigenetic factors comprise of post-translational histone modifications, nucleosomal 
remodelling, chromatin looping, certain non-coding RNAs and DNA methylation. 
DNA methylation is a chemical modification that primarily affects cytosines when these are followed 
by guanines in a 5’-3’ direction in the DNA double helix and, in mammalian cells, results in the 
addition of a methyl group (-CH3) to their 5’ carbon (C5). These 5’-3’ CG methylation sites in the 
DNA are called ‘CpG’ dinucleotides and are mostly methylated in the human genome (70-80%) [33]. 
The unmethylated CpGs are predominantly encountered in groups of high CG density known as ‘CpG 
islands’ most commonly located at the 5’ end of the regulatory region of genes [34]. Their position 
around the regulatory region of genes, as well as the fact that approximately 60% of human genes 
[34] can be linked to specific CpG islands, suggests methylation’s key role in modulating gene 
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expression [31]. Although a general tendency for hypo-methylation with age has been observed in 
the human genome [35-37], recent studies have brought to light evidence suggesting that methylation 
can also occur de novo in regions related to key developmental genes [38-40], highlighting a role in 
the physiological process of human ageing.  
Since the first evidence of correlation between human ageing and DNA methylation, a significant 
amount of research has been conducted in this direction. A methylation-based age prediction method 
incorporating data from various CpG sites was proposed as early as 2010 by Teschendorff et al. in 
their study [40], followed by Horvath’s epigenetic ‘ageing clock’ formed by 353 age-correlated CpG 
sites in 2013 [41]. Furthermore, in addition to models using large numbers of methylation sites, a 
number of age estimation models have been successfully developed based on less than 10 CpG sites 
[30, 42, 43] suggesting the high potential of DNA methylation in age determination. 
Recent studies on DNA methylation have also identified a number of characteristics that highlight 
the potential of this approach for forensic applications where the number of unknown variables in 
regard to the DNA source increases drastically. The majority of studies on DNA methylation and age 
correlation have failed to identify any sex-specific bias for age-related CpG sites [37, 42, 44-47], 
while a recent study suggests that ethnicity can also be excluded as a factor of bias [48]. Furthermore 
studies have shown no significant changes in the methylation status when comparing samples of 
living and deceased individuals [45, 49] or fresh and long stored samples [43, 46, 50-52] suggesting 
a high stability for DNA methylation that can contribute significantly to the robustness of a DNA 
methylation based assay. 
On the other hand, there are points raised by the literature that require further investigation if a method 
is to be applied in forensics. While a number of studies have been able to identify CpG sites exhibiting 
similar correlation with age between two or more distinct tissues [31, 39-41, 49, 53, 54], several 
studies report tissue specificity of their age-related CpG sites and subsequent failure to reproduce 
predictions in multiple tissues [32, 41, 46, 55-60]. These results suggest that differential methylation 
with age might be similar or significantly different between different tissues depending on the specific 
CpG site and, therefore, when designing an age-prediction model for forensic applications the multi-
tissue applicability of the method should be investigated thoroughly. Furthermore, it is possible that 
the ideal DNA methylation-based age estimation tool that would be applicable to all tissues might not 
be a feasible target and tissue specific models should be designed instead. A second issue highlighted 
by current research is that of the effect of various health and environmental factors on the methylation 
status of age related CpG sites [32, 41, 61-64] which introduces a new parameter that needs to be 
investigated when validating an age prediction model based on DNA methylation. Finally, two other 
 4 
 
important factors to consider when designing a method for application in forensics is target size and 
sensitivity, as DNA evidence recovered from crime scenes is often of poor quality and low quantity. 
Methods based on amplicons over 300bp long [43, 44], or DNA material requirements higher than 
100ng [30, 44, 46, 49, 53] might not be applicable to degraded DNA samples. A limited number of 
reports have been recently published using more forensically relevant quantities of bisulphite-
converted DNA in the PCR stage. In their studies, Naue et al. as well as Zbieć-Piekarksa et al. have 
reportedly achieved high prediction accuracy using as little as 10ng in the PCR stage [43, 65], while 
similar studies have reported promising results using 20ng of DNA in the same stage [45, 66].  
The quantification of DNA methylation for age estimation is currently conducted with four main 
methods: (i) pyrosequencing, (ii) the EpiTYPER system based on MALDI-TOF mass spectrometry, 
(iii) methylation SNaPshot and (iv) massively parallel sequencing (MPS). Although all these 
techniques have been successfully applied in age estimation, massively parallel sequencing appears 
to be the best candidate for forensic applications as it is characterised by high sensitivity, single base 
resolution and large multiplexing capabilities. Furthermore, the MPS technology has been 
successfully applied to multiple aspects of forensic analysis [67-71] and DNA methylation-based age 
prediction methods have been recently attempted on the MPS platform providing promising 
preliminary results, with one method reporting a mean average deviation (MAD) of 4.4 years between 
the true and the predicted age of the donors using 16 markers [72] and a second reporting a MAD of 
3.2 years using both 13 or a sub-selection of 4 markers [65]. 
Finally, when it comes to correlating DNA methylation data and age in a prediction model, a variety 
of different statistical approaches have been adopted by the various research groups. Most prediction 
models so far have been developed using linear univariate [43, 46, 48, 53] or multivariate least-
squares regression analysis [30, 44, 64]. However, the success of recent machine learning approaches 
[65, 72, 73] has begun to raise doubts on the ability of linear models to truly grasp the complexity of 
the relationship between the DNA methylation state and human ageing [44, 49, 61]. However, even 
with recent publications focusing on models applying complicated algorithms [65, 72, 73], there has 
been no detailed comparison, to this day, on the efficiency and complementarity of the different 
modelling approaches when it comes to methylation-based age prediction.   
The aim of this study is to systematically optimise all the parameters of a methylation-based age 
estimation assay in order to make this type of analysis realistic in a forensic scenario. From assessing 
the robustness of the method through reproducibility experiments, to selecting the optimal statistical 
approach for the predictive modelling and investigating into parameters such as sensitivity and multi-
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tissue applicability, this study attempts to break down a 12 CpG assay based on the marker selection 
by Vidaki et al. in 2017 [72] and place it under the forensic microscope.  
 
2. Materials and Methods 
2.1 Sample Collection 
This study operated under ethical approval granted by the Biomedical Sciences, Dentistry, Medicine 
and Natural & Mathematical Sciences Research Ethics Subcommittee (BDM/13/14-30) in regards to 
sample collection from various tissues for DNA methylation analysis. Whole blood samples were 
collected from a total of 110 unrelated donors aged 11 to 92.9 years through venepuncture. 
Additionally, 34 saliva samples and 11 semen samples were collected from unrelated donors aged 
between 16-90.5 and 23-50 respectively by deposition in 15mL universal receptacles. Full informed 
consent regarding the analysis was acquired prior to sampling from the donors or their parents or 
legal guardians for the cases of under-aged individuals. Samples were stored at 4oC. All semen donors 
are also part of the saliva sample set, while blood donors originated from a different group of 
participants. All samples were unconnected to any disease study, and information was not collected 
regarding medical history of the donors in the effort to create an inclusive, unbiased dataset that would 
be representative of the general population.  
 
2.2 DNA Standards of known methylation 
In order to assess the sensitivity of the method two pre-mixed methylation standards (EpigenDx, 
Massachusetts, USA) corresponding to 5% and 25% methylation were used in inputs of 50, 25, 10 
and 1ng. 
 
2.3 DNA Extraction and Quantification 
Genomic DNA extractions were carried out using a BioRobot®EZ1 automated purification 
instrument (Qiagen, Hilden, Germany) in combination with the EZ1 Blood kit for whole blood 
samples and the EZ1 DNA Investigator kit for all other samples. For semen samples, differential 
extraction was performed in combination with the BioRobot®EZ1 and EZ1 DNA Investigator kit, in 
order to separate the sperm and epithelial fractions and only the sperm fraction was analysed further. 
Samples were subsequently stored at -20°C. Quantification of DNA extracts was conducted using the 
Quantifiler® Trio DNA Quantification kit in combination with the ABI PRISM® 7500 Sequence 
Detection System, both provided by Thermo-Fisher Scientific (Massachusetts, USA). The 
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manufacturer’s guidelines [74] were followed throughout the protocol in half volumes and all samples 
were quantified in duplicates. 
  
2.4 Sodium Bisulphite Conversion 
Treatment with sodium bisulphite was employed for the conversion of unmethylated cytosines to 
uracils in the DNA samples. A total of 50ng of DNA from each sample or calibration standard was 
treated using the MethylEdge® Bisulphite Conversion System (Promega Corporation, Wisconsin 
USA) and the converted DNA was eluted in 10µL of the elution buffer provided. Eluates were stored 
at 4°C for up to a week and at -20°C up to one month according to the manufacturer’s guidelines [75]. 
The approximate recovery of DNA following bisulphite conversion using this chemistry has been 
calculated as 52% [76] and therefore the final concentration of the eluate is estimated at 
approximately 2.6ng/µL. 
 
2.5 Age-associated CpG sites 
This study is based on 12 out of the 16 CpG sites previously described by Vidaki et al. [72] in 2017. 
Removal of the remaining 4 markers was deemed necessary due to their poor amplification efficiency 
and low overall contribution to the prediction accuracy. Information on the location and gene 
association of the CpGs is displayed in Table 1. Primers used in this study are of the same design as 
those originally described by Vidaki et al. [72] with the exception of cg17274064 for which primers 
were redesigned to improve the amplification efficiency (Forward primer sequence: 
GGGAGGGAATAAGTATTTTTTTAA, Reverse primer sequence: 
ACAACTAAAATAACTCCACTTTC). 
 
2.6 Amplification of the bisulphite-converted DNA 
Amplification of DNA following bisulphite treatment was performed using two multiplex reactions, 
the first containing primers for the amplification of amplicons 1-7 (Table 1) and the second targeting 
amplicons 8-12 (Table 1). The Qiagen Multiplex PCR kit was used for both reactions in half volume 
(25µL). Each reaction comprised of 12.5µL of 2x Qiagen Multiplex PCR Master Mix (providing a 
concentration of 3mM MgCl2), an additional 1µL of 25mM MgCl2 solution for a final concentration 
of 4mM, 2µL (~5ng) of bisulphite treated DNA or calibration standard and 9.5µL of primer mix. The 
final concentration of primers in the two multiplex reactions ranged from 0.2 to 0.5µM depending on 
the efficiency of the primers (Table 2).  The reaction conditions were: (1) 95°C for 15min, (2) 32 
 7 
 
cycles consisting of 94°C for 30s, Tm (see Table 2) for 30s and 72°C for 30s, (3) 72°C for 4min 
followed by a hold at 4°C (Table 2).  
 
2.7 Post-PCR Purification and Quantification 
Following amplification, samples were purified using the MinElute® PCR Purification kit by Qiagen 
in order to remove unincorporated primer residues [77]. Elution was performed in 11µL PCR-grade 
water. Prior to library preparation all samples were quantified using the Qubit® dsDNA HS Assay 
kit (Thermo Fisher Scientific) according to the manufacturer’s guidelines [78] and in combination 
with the Qubit 2.0 Fluorometer instrument and clear thin-walled 0.5mL PCR tubes. 
 
2.8 Library Preparation and Quantification 
The preparation of sequencing libraries was performed with the Kapa Hyper Prep® kit for Illumina 
(Roche, Basel, Switzerland) starting with 50ng of purified PCR product per sample. Library 
preparation was performed according to the manufacturer’s specifications [79] in half volumes. For 
the size selection stages, AMPure® XP Beads (Beckman Coulter Genomics, California USA) and 
Illumina Resuspension Buffer were used (Illumina, California USA). Finally, library amplification 
was performed for 8 cycles.  
Quantification of the libraries was conducted with the KAPA Library Quantification Kit for Illumina 
platforms (Roche) [80]. Libraries were diluted 1:4000 in PCR-grade water prior to quantification and 
analysed in duplicate. Following quantification, DNA libraries were normalised to 20nM using Tris-
HCL 10mM/ pH 8.5 with 0.1% Tween (EBT buffer) and were pooled together in equal amounts to a 
final volume of 240µL (24 samples per run). Following denaturation and dilution to 10pM, 500µL of 
library was mixed with 100µL of denatured 20pM PhiX control (Illumina) and loaded in the 
MiSeqFGx instrument (Illumina) using the MiSeq version 2 cartridge and reagents. 
 
2.9 Sequencing 
Sequencing of the libraries was performed using the Illumina MiSeqFGx benchtop instrument 
(Illumina). Sample sheets and sample plates were created in the Illumina Experiment Manager 
software and the instrument was set to perform paired-end sequencing of 151bp in each direction 
while the analysis workflow was set to ‘FASTQ only’. The online platform Basespace® (Illumina) 
was used for monitoring the performance of the runs as well as retrieve the sequencing files.  
 
2.10 Data Analysis and Normalisation 
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Analysis of the FASTQ files was conducted with the Burrows-Wheeler Aligner (BWA) [81], 
Sequence Alignment/Map (SAMtools) [82], and Genome Analysis Toolkit (GATK, Broad Institute, 
Massachussets USA) [83] software. Sequences were aligned to a custom genome where all non-CpG 
cytosines were replaced by thymines. For CpG positions information was collected for the presence 
of both cytosines and thymines. Files were extracted in variant call format (VCF) using the R® 
Project for Statistical Computing software in combination with R Studio® platform and were 
subsequently processed with Microsoft Office Excel software. The methylation percentage (ß-values) 
for the 12 targeted CpGs was calculated by comparing the number of cytosine reads (suggesting the 
presence of methylation) to the combined total of cytosine and thymine (suggesting the absence of 
methylation) reads at each locus. A similar analysis was carried out for all non-CpG cytosine sites in 
each locus in order to establish the conversion efficiency of the bisulphite treatment. Non-CpG 
cytosines are expected to be free of methylation [84, 85] and therefore should be converted to uracils 
and subsequently to thymines following bisulphite treatment and amplification. Any cytosines 
therefore detected in those positions are indicative of incomplete conversion and the methylation 
percentages for the relevant CpGs were corrected accordingly. Average methylation values between 
duplicates was calculated based on the number of sequencing reads for each duplicate and each 
marker, where the methylation value of the duplicate with the higher number of sequencing reads 
contributed accordingly high to the final methylation score for the relevant marker following the 
equation:  
 
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑚𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑖𝑜𝑛 𝑣𝑎𝑙𝑢𝑒 𝑓𝑜𝑟 𝐶𝑝𝐺𝑖
= (𝐶𝑝𝐺𝑖 𝑀𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑖𝑜𝑛 𝑉𝑎𝑙𝑢𝑒 𝑎) ∗ (
(𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑎)
𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑎 + 𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑏
)
+ (𝐶𝑝𝐺𝑖 𝑀𝑒𝑡ℎ𝑦𝑙𝑎𝑡𝑖𝑜𝑛 𝑉𝑎𝑙𝑢𝑒 𝑏) ∗ (
𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑏
𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑎 + 𝐶𝑝𝐺𝑖 𝑅𝑒𝑎𝑑𝑠 𝑏
)   
 
Where CpGi corresponds to a specific marker and a and b correspond to the two replicates of the 
specific sample. Prior to statistical analysis and modelling methylation ß-values were converted to 
M-values following the equation: 
 
𝑀𝑖 = 𝑙𝑜𝑔2(
ß𝑖
1 − ß𝑖
) 
 
where Mi represents the M-value for a certain marker in a specific sample and ßi represents the 
equivalent ß-value, and were normalised by centring around the median value for the dataset. Datasets 
corresponding to different tissues were normalised separately. 
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2.11 Age Prediction  
For model fitting, the whole blood dataset was randomly split into training (70%, n=76) and validation 
(i.e., blind) subsets (30%, n=33). Using the training dataset, different software was then used to assess 
different kinds of models. 
The Trajan® Neural Network Simulation package (Trajan Software Ltd., Durham UK) was employed 
in order to perform generalised regression neural network modelling (GRNN), an artificial neural 
network modelling approach that uses radial basis and linear functions together to rapidly learn from 
existing knowledge and produce a prediction output (i.e. age), and provide a direct comparison to 
previously reported results [72]. Parameter tuning was performed by holdout cross-validation using 
an internal verification subset composed by 10 out the 76 samples used for training. During each 
training round the software was set to develop 106 networks and display the best 50. Those networks 
were subsequently assessed on the degree and consistency in prediction accuracy across the training 
and verification subsets and the best networks were put through a new round of training until the 
point when no further improvement was observed.  
Additionally, R project for statistical computing software version 3.3.3 in combination with the caret 
package [86] was employed in order to test fourteen regression methods: ordinary linear (LM), partial 
least squares (PLS), ridge regression (Ridge), elastic net (Enet), lasso regression (LASSO), bagging 
multivariate adaptive regression splines (BagMARS), k nearest neighbours (KNN), extreme learning 
machines (ELM), single-layer feedforward perceptron neural network using a single hidden layer 
(NNet.SLP) and two hidden layers (NNET.2MLP), support vector machines with radial (SVMr) and 
polynomial function (SVMp) as kernels, random forest exploiting classification trees algorithms as 
base learners (RFclass) and boosted trees (BT). Parameter tuning was performed by leave-one-out 
cross-validation.  
All models were finally validated using the validation (blind) subset. Both the GRNN networks and 
R models were trained and blind tested using the same sample subsets. 
 
2.12 Statistical analysis 
The comparison of the different models was based on root-mean-square error (RMSE). Mean absolute 
error and median absolute error values were also used for the purpose of comparison with previous 
studies. In order to assess the similarity of the developed statistical models, residuals for the different 
samples were compared between the models using analysis of variance (ANOVA) and paired t-test 
with Bonferroni post-hoc correction. Additionally, a general classification and regression tree model, 
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pruning on error, was employed to group the different models based on similarity of the residuals. 
The attempt to combine the different approaches was carried out by selecting the best performing 
model of each group (based on RMSE) and averaging the predicted ages between those models. 
 
3. Results and Discussion 
3.1 Reproducibility assessment 
The first step in assessing the validity of this method was to establish its reproducibility in terms of 
the quantification of DNA methylation. In order to investigate this, 110 blood samples were put 
through the process in duplicate starting from the bisulphite conversion stage. The average absolute 
difference in methylation between duplicates was calculated to be less than 3% for all markers (Fig.1). 
Taking into account the range in DNA methylation observed in the 12 markers used in this study 
(between 20-40%) a maximum of 3% average difference in methylation quantification between 
replicates was considered a satisfactory result. 
 
3.2 Development of an age prediction model using Generalised Neural Networks 
In the prediction model described by Vidaki et al. the mean absolute prediction error (MAE) 
calculated during the development of the model using publicly available methylation data increased 
from 3.3 to 7.1 years of age when the model was applied to data collected in-house via an MPS 
method even after normalisation had been applied [72]. Variation in the technical aspects of a DNA 
methylation quantification method has been shown to affect the final methylation values obtained 
and, thus, would be expected to affect prediction accuracy between different datasets [42]. For this 
reason, this increase in the prediction error was believed to occur partly due to variations in the 
processing of samples as well as the sequencing techniques between the BeadChip array 
methodology, used to generate the data included in the publicly available datasets, and the 
forensically orientated method developed in this study. In order to investigate the magnitude of this 
platform-based effect, the age prediction model was retrained using the same statistical modelling 
approach but restricting the training dataset to data solely generated with the developed MPS method. 
Blood samples from 110 individuals of known age were analysed in duplicate and the results were 
subsequently used to train (66 samples), validate (10 samples) and blind test (33 samples) a 
generalised regression neural network for age prediction using the same software as the previous 
publication [72]. The distribution of different ages in the dataset is shown in Figure 2.  
The mean absolute prediction error of the model was calculated at 0.8 years of age for the training set 
(n=66), 2.8 years of age for the validation set (n=10) and at 4.7 years for the external blind test set 
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(n=33) (Fig.3) placing the developed model amongst the most accurate ones using a limited number 
of markers published to this day [30, 44, 47, 65]. This prediction error is very similar to the expected 
mean absolute prediction error calculated in the BeadChip array training data of the original model 
(3.3 years) [72], suggesting that the previous loss of accuracy was indeed a result of inter-method 
variability. Furthermore, the high similarity in the accuracy of the two models is impressive given the 
fact that the model developed in this study was trained with approximately 13 times fewer samples 
than the original model developed by Vidaki et al. [72]. However, this apparently high performance 
is perhaps offset somewhat when comparing the training and verification set prediction accuracies to 
that of the external blind test set accuracy. It was apparent that this artificial neural network approach 
may have suffered from shortcomings with generalisability using fewer training cases (e.g. over-
training, etc.).  
  
3.3 Evaluating the efficiency of different modelling approaches 
While statistical modelling using generalised regression neural networks (GRNN) generated an age 
prediction model with a relatively low mean absolute prediction error and root square mean error 
(RMSE=5.8 years), several factors, including its susceptibility to overfitting and loss of 
generalizability when the training dataset is small (n<1000), suggested that this modelling approach 
is less than ideal for this set of data. A GRNN ensemble model consisting of 6 individual GRNNs 
was also developed in an attempt to further stabilize the algorithm and increase its ability to generalize 
but the prediction error obtained in the blind test set for this model was very similar to that of the 
single GRNN (RMSE=6.1 years, MAE=4.9 years). In order to determine the optimal approach, 15 
additional statistical models were trained using an identical training subset. While MAE is the most 
popular statistics for reporting prediction errors in this type of application, RMSE is a more 
appropriate statistic for comparing the performance of different prediction algorithms developed on 
the same dataset and thus it was chosen for this study. Based on this comparison and while linear 
models did not outperform the GRNN model, several non-linear approaches showed increased 
accuracy, with the support vector machine with polynomial function (SVMp) giving an RMSE of 4.9 
years (MAE=4.1 years) in the validation subset (Fig.4). 
Comparison of the individual sample residuals between models (i.e. the difference between the actual 
and predicted age for each sample, with every model) revealed no significant difference in the 
prediction error for 15 out of 17 models, with the exception of the Bagging Multivariate Adaptive 
Regression Splines (BagMARS) and the Neural Network 2 Layer Perceptron (NNet.2MLP). 
Furthermore, analysis of variance showed a significant difference in the error between the 
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NNet.2MLP and the rest of the models (p<0.0017) on post hoc analysis. Finally, using a general 
classification tree model, pruning on the error, the different models were separated in 4 groups based 
on the similarity of the residuals for the different samples. Based on these observations, an attempt to 
combine the predictions across the different groups, by averaging the predicted ages for the different 
samples for the best performing model of each group with each other, was made but this did not result 
in any increase in accuracy compared to the best performing individual model (SVMp). This result 
suggests that a considerable proportion of the prediction error in this dataset is sample specific rather 
than depended on the statistics behind the prediction model used, meaning that different samples 
predict with a similar level of accuracy across all models tested. It is possible, however, that this is a 
result of the limited training dataset and a prediction method developed on a larger dataset could 
benefit from the combination of multiple independent statistical approaches that would introduce 
orthogonality into the statistics enabling confidence interval estimations. In this case, taking the 
previous results into account, the SVMp model was chosen for further applications of this age 
prediction method (Fig.5). 
 
3.4 Sensitivity assessment 
Having optimised this age prediction model and assessed the reproducibility of this analysis at 
standard amounts of DNA input (50ng), for the assay to be forensically relevant it should also be 
applicable to forensically relevant levels of DNA. The next steps of this study were designed to test 
this prediction method in a more realistic set of conditions, starting with a lower DNA input. Two 
methylation standards corresponding to 5% and 25% methylation were analysed starting with an 
initial input (before bisulphite conversion) of 50 (optimum), 25, 10 and 1ng. It is important to note 
that while these amounts correspond to the original DNA quantity used for the analysis, the final 
input in the PCR, following bisulphite conversion (approximately 52% recovery [76]) with elution at 
10µL and use of 2µL for each of the 2 multiplex reactions, was calculated to be approximately 10, 5, 
2 and 0.2ng respectively. The analysis was performed in duplicate and the methylation values 
obtained were compared with the average value for the 50ng input which is the optimum input upon 
which the method was developed (Fig.6). The accuracy in the quantification of DNA methylation 
was retained down to 10ng of initial input (~2ng in the PCR stage) and, while certain markers 
(cg07158339, cg0693994, cg20692569) retained their accuracy down to 1ng of initial input (~200pg 
in the PCR stage), for most markers an increase in the quantification error was observed when 1ng 
was used as starting material. These results correspond with the findings reported by Naue et al. in 
2018, where through simulation experiments the authors suggest that an input in the order of 5ng can 
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be used to detect differences in methylation of approximately 10% but higher inputs are required in 
order to achieve resolution any higher than this [87]. 
Furthermore, whole blood samples from 6 donors of known age (21.3-79.7 years old) were also 
analysed in duplicate starting with different DNA quantities. The same initial DNA inputs of 50 
(optimum), 25, 10 and 1ng were used and the methylation values obtained were used for the 
generation of age estimates from the age prediction model. Comparison of the error in age prediction 
(MAE) obtained for the different DNA inputs suggests that, while the accuracy of the predictions is 
retained down to 10ng of original DNA input (~2ng in the PCR stage), the error in age prediction 
increases significantly (p<0.05), at approximately 5-fold, when 1ng is used as starting material 
(Fig.7). These results are a direct match to the results obtained from the previous experiment where 
the accuracy in methylation quantification is shown to be compromised for PCR inputs below ~2ng 
for most markers (Fig.6) and once again correspond with the observations made by Naue et al. in 
2018 [87]. Although a limit of ~2ng is not comparable to that of highly sensitive forensic methods 
and thus further improvement is required for the method to be universally applicable to forensic 
investigations, it still has the best sensitivity reported to this day for DNA methylation based age 
prediction [30, 43-47], providing encouraging results for the future of this study. While previous 
publications have reported successful DNA methylation-based age prediction using DNA amounts as 
low as 10-20ng [43, 45, 65, 66], this value refers to the PCR input rather than the original DNA 
amount used for bisulphite conversion and thus corresponds to the highest input used in this study. 
Furthermore, given the fact that the proposed method is currently targeted at blood samples rather 
than contact traces, a higher DNA yield is expected. Finally, given the rapid increase observed in both 
quantification error and prediction accuracy between 10 and 1ng this range should be investigated 
further in the future in order to determine the true ‘tipping point’ in the sensitivity.  
 
3.5 Application in different tissues 
Finally, while this DNA methylation quantification method and age prediction model were developed 
on whole blood, their applicability to saliva and semen, which together with blood form the three 
most commonly encountered body fluids in forensic investigations, was investigated. A total of 34 
saliva and the sperm fractions of 11 semen samples were analysed with the developed method. The 
reason behind choosing to analyse the sperm fraction instead of the whole semen lies with the 
increased complexity of a tissue consisting of both sperm and epithelial cells as well as the fact that 
in real life cases any potential age prediction assay would be performed following traditional DNA 
analysis which, in the majority of cases involving semen stains, would require differential extraction 
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for the isolation of the sperm fraction. Methylation values corresponding to the samples of the two 
tissues where put through the prediction model following normalisation and resulting in a successful 
age prediction for the saliva samples with a mean absolute prediction error of 7.3 years (Fig.8).  The 
relatively low increase in the prediction error in saliva, especially given the fact that this method was 
targeted on whole blood and the prediction model was trained solely on data deriving from whole 
blood samples, suggests that a common model for DNA methylation-based age prediction can be 
developed for both whole blood and saliva. More importantly, these results correspond with previous 
findings suggesting that certain age-correlated DNA methylation markers can be applicable to more 
than one tissues [31, 39-41, 49, 53, 54]. The next step from this would be to re-train a model solely 
on saliva samples while keeping the same marker set. However, this was not possible in this study 
due to the limited number of available samples.  
On the other hand, in the case of sperm tissue, no methylation (0%) was detected for any marker in 
any of the samples, deeming any attempt to predict chronological age with this marker set 
meaningless. Similar results, with age prediction methods applied successfully to both blood and 
saliva but failing to produce good results in semen, have been previously reported [60] and a possible 
explanation for these findings could be the methylation reprogramming that is known to occur during 
gamete formation [88]. Even though there are published studies suggesting that DNA methylation in 
semen can be used for age prediction it is not clear if these results represent the sperm or the epithelial 
fraction of the semen, since the analysis is taking place in whole semen samples [56, 60].  Even when 
the epithelial fraction is markedly low compared to the sperm fraction in a semen sample, large 
differences in the methylation values between the two could result in a notable difference in the DNA 
methylation quantification values obtained from whole semen when compared with sperm for the 
same sample. It is however, possible that through mechanisms of genetic imprinting, certain 
methylation sites in the gamete DNA would represent the chronological age of the donor and therefore 
could potentially be used in age prediction. 
 
4. Conclusions 
The results obtained from this study provide strong evidential support to recent publications 
suggesting that a DNA methylation-based age prediction method can be developed in a way 
applicable to forensic casework. The small amplicon size (<200bp) and the relatively high sensitivity 
(~10ng of initial DNA extracted from a crime scene stain or ~2ng of bisulphite treated DNA) suggest 
that there is potential for such a method to be applied to forensic samples of poor quality and/or low 
quantity. At the same time, the relatively large number of predictors, incorporated in the two 
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multiplex reactions described in this method, allows for the inclusion of multiple genomic locations 
and thus enhances the robustness [46] without compromising the sensitivity. Furthermore, this study 
addresses the issue of statistical modelling for methylation analysis of relatively small datasets and 
comes to the same conclusion as Xu et al. [73], suggesting that support vector machines offer a 
potentially more robust, accurate and generalizable modelling approach. With a training/validation 
set consisting of 76 whole blood samples, the developed model was able to successfully predict the 
chronological age of 33 new samples with a mean absolute error (MAE) of 4.1 years and a root mean 
square error (RMSE) of 4.9 years. While the MAE statistic is used throughout this study in order for 
the results to be comparable with relevant publications [30, 43, 45, 46], RMSE was used both to 
compare between the different models tested and to describe the accuracy of the selected model. This 
measure, previously adopted by other studies [30, 31, 46, 49, 60, 65, 89], was selected due to its 
ability to describe both the mean and the spread of the deviation/error within a specific dataset. In 
order to simplify any comparisons this study also reports the median absolute error (3.8 years) and 
the percentage of samples within a certain error ranges (52% of the samples predicting with less than 
4 years of error and 86% with less than 7 years) for the final prediction model, following the layout 
chosen by previous publications [43, 44]. An important note on the reported accuracy of the model is 
that unlike most studies on forensically orientated DNA methylation-based age prediction that focus 
on adults (over the age of 18 years), in this study the dataset also includes younger individuals starting 
at 11 years of age. Removing these samples from the dataset could potentially improve the prediction 
accuracy of the proposed method even further as it has been shown that methylation patterns can 
differ between adulthood and childhood for certain markers [90] most likely due to the high activation 
of the immune system and development during the first years of life [91]. This is the first method, to 
our knowledge, to achieve a combination of age prediction accuracy and sensitivity of this magnitude 
and it provides strong evidence to suggest that a DNA methylation-based age prediction method 
applicable to forensic casework samples can be successfully developed. Furthermore, this prediction 
method was successfully applied to saliva samples with 50% of the samples predicting with less than 
4 years of error and 70% with less than 7 years (MAE=7.3 years, RMSE=11.1 years), suggesting that 
an age estimation method applicable to multiple tissues is a realistic target for forensically orientated 
DNA methylation-based age prediction methods employing a limited number of predictors. Overall, 
this is the first study of its kind to take a DNA methylation-based age prediction method designed for 
forensic analysis further than the proof-of-concept stage, testing its sensitivity, statistical modelling 
and multi-tissue applicability, all at the same time. However, while this is a step forward towards the 
implementation of this type of analysis in the forensic field, it is only one of many required, with the 
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investigation of larger datasets as well as the use of extensive cross-validation being the first ones to 
follow. 
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Marker CpG Chromosomal location Gene 
1 cg04084157 7: 100,809,049 VGF – nerve growth factor inducible precursor 
2 cg02085507 19: 6,739,192 TRIP10 – thyroid hormone receptor interactor 10 
3 cg04528819 7: 130,418,315 KLF14 – Kruppel-like factor 14 
4 cg19761273 17: 80,232,096 CSNK1D – casein kinase 1; delta isoform 1 
5 cg20692569 7: 72,848,481 FZD9 – frizzled 9 
6 cg27544190 21: 33,785,434 C21orf63 – chromosome 21 open reading frame 63 
7 cg01511567 11: 57,103,631 SSRP1 – structure specific recognition protein 1 
8 cg22736354 6: 18,122,719 NHLRC1 – malin  
9 cg17274064 21: 40,033,892 ERG – v-etseryhtroblastosis virus E26 oncogene like isoform 2 
10 cg07158339 9: 71,650,237 FXN – frataxin, mitochondrial isoform 1 preproprotein  
11 cg05442902 22: 21,369,010 P2RXL1 – purinergic receptor P2X-like 1; orphan receptor 
12 cg06493994 6: 25,652,602 SCGN – secretagogin precursor 
 
Table 1 - Chromosomal location and genetic information on the 12 CpG sites employed in this study. 
  
Marker CpG 
Primer concentration in 
multiplex PCR (µM) 
Annealing temperature 
1 cg04084157 0.3 
50°C for the first 7 cycles and 48°C for the next 25 cycles 
2 cg02085507 0.4 
3 cg04528819 0.3 
4 cg19761273 0.5 
5 cg20692569 0.5 
6 cg27544190 0.4 
7 cg01511567 0.2 
8 cg22736354 0.3 
52°C 
9 cg17274064 0.4 
10 cg07158339 0.4 
11 cg05442902 0.3 
12 cg06493994 0.2 
 
Table 2 - Details of the multiplex reactions employed in this study. 
  
 
 
Figure 1 - Average absolute difference between duplicates (n=110) for the 12 different markers. The error bars represent 
the standard error. 
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Figure 2 - Distribution of blood samples used in the model between the different age groups in the training (orange, 
n=66), validation (yellow, n=10) and test set (green, n=33). 
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Figure 3 - Comparison between the predicted and the true age for the training (blue, n=66), validation (orange, n=10) 
and blind test set (red, n=33). The mean absolute prediction error was calculated at 0.8, 2.8 and 4.7 years respectively. 
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Figure 4 - Combined graph of the residuals (grey) and RMSEs (red) for the blind test set (n=33) for the different statistical 
models. 
  
 
 
Figure 5 - Comparison between the predicted and the true age for the training (blue, n=76) and blind test set (red, n=33) 
in the SVMp model. The mean absolute prediction error was calculated at 4.0 and 4.1 years respectively. 
  
y = 0.8852x + 4.9812
0
20
40
60
80
100
0 20 40 60 80 100
P
re
d
ic
te
d
 a
ge
 (
ye
ar
s)
True age (years)
  
Figure 6 - Amount of initial DNA input (ng) and the absolute difference in the quantification of DNA methylation form 
the 50ng input (optimum), for all 12 CpG sites. Two different pre-mixed methylation standards were used in this 
assessment, the first corresponding to 5% (light blue) and the second to 25% methylation (dark blue). 
  
 
 
Figure 7 - Amount of initial DNA input (ng) (x axis) and MAE for age prediction for 6 blood samples analysed in 
duplicate. The estimated DNA input (ng) in the PCR stage (post-bisulphite treatment) is also depicted in the graph. 
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Figure 8 - Comparison between the predicted and the true age for 34 saliva samples using the age prediction model 
developed in whole blood using Support Vector Machines with polynomial kernel function (SVMp). The mean absolute 
prediction error was calculated at 7.3 years and the root mean square error at 11.1 years. 
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